Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Vincent, P. Meredith, H. Elliott, J. Reid (1986)
The pharmacokinetics of doxazosin in elderly normotensives.British journal of clinical pharmacology, 21 5
D. Cox, J. Leader, J. Milson, W. Singleton (1986)
The antihypertensive effects of doxazosin: a clinical overview.British journal of clinical pharmacology, 21 Suppl 1
MH Frick, P. Halttunen, P. Himanen, M. Huttunen, P. Porsti, T. Pitkäjärvi, L. Poyhonen, Pyykönen Ml, P. Reinikainen, P. Salmela (1986)
A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.British journal of clinical pharmacology, 21 Suppl 1
JG Wagner (1971)
Drug Intelligence Publications
J. Wagner (1971)
Biopharmaceutics and Relevant Pharmacokinetics
P. Rubin, P. Scott, J. Reid (1981)
Prazosin disposition in young and elderly subjects.British journal of clinical pharmacology, 12 3
P. Lund-johansen, P. Omvik, H. Haugland (1986)
Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.British journal of clinical pharmacology, 21 Suppl 1
P. Lund-johansen (1975)
Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.Postgraduate medicine, Spec No
J. McNeil, O. Drummer, E. Conway, B. Workman, W. Louis (1987)
Effect of Age on Pharmacokinetics of and Blood Pressure Responses to Prazosin and TerazosinJournal of Cardiovascular Pharmacology, 10
J. Vincent, H. Elliott, P. Meredith, J. Reid (1983)
Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man.British journal of clinical pharmacology, 15 6
D. Cooper (1982)
Temporary cardiac pacing via the oesophagusPostgraduate Medical Journal, 58
A. Nies (1977)
Clinical pharmacology of antihypertensive drugs.The Medical clinics of North America, 61 3
GS Stokes (1984)
Clinical pharmacology of antihypertensive drugs, Handbook of Hypertension
F. Sacks, V. Dzau (1986)
Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action.The American journal of medicine, 80 2A
The pharmacokinetics of doxazosin were determined in hypertensive subjects after a single dose of 1mg, and at steady-state while receiving doses of 1, 2, 4 and 8mg of the drug daily. Chlorothiazide 500mg once daily was administered as additional therapy throughout the study. After a single dose doxazosin was rapidly absorbed, with peak plasma drug concentrations (Cmax) occurring after 2.1 ± 0.4 hours. The elimination half-life in plasma was 10.7 ± 1.2 hours. These parameters remained essentially unchanged during maintenance administration of doxazosin at each of the dose levels. Calculations of Cmax and area under the concentration-time curve (A UC0→∞) indicated that the pharmacokinetic disposition of the drug remained linear over the dose range 1 to 8mg.
Clinical Pharmacokinetics – Springer Journals
Published: Nov 4, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.